Dermatitis, Atopic
Conditions
Keywords
Behavioral Research, Emollients
Brief summary
Atopic dermatitis is the most common chronic inflammatory skin disease in children and severely affects quality of life (QoL) of patients and their parents. The application of topical medications and emollient is the mainstay of the treatment, but complexity of the treatment and lack of self-care knowledge cause poor adherence, leading to therapeutic failure. Adequate education about the chronic disease and its treatment was known to improve the treatment adherence. There are a variety forms like generalized information leaflets and video clips for imparting information to patients and individualized tailoring education was considered more effective way to improve patients' adherence. The aim of this study is to determine the efficacy of tailored education in dermatology area, especially the emollient usage in patients with atopic dermatitis.
Interventions
BEHAVIORALTailored leaflet group
Parents in intervention group will receive an patient education leaflet and watch an educational video about lifestyle recommendations, and the use of emollients. In addition to general information, parents in intervention group will also receive the tailored leaflet including the estimated amount of emollients based on the body surface area.
BEHAVIORALControl group
Participants (parents of children with atopic dermatitis) in control group will receive an patient education leaflet and watch an educational video about lifestyle recommendations, and the use of emollients.
Sponsors
Seoul National University Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* A parent of 0-5 year old children with mild to moderate atopic dermatitis * 20 years of age or older * Apply emollient for themselves to their children with atopic dermatitis
Exclusion criteria
* Parents of children with severe atopic dermatitis or showing signs of acute infection (Oozing, vesicles, edema, redness or pain)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of the weekly amount of emollient used | Two weeks | Parents of patients are asked to bring the emollients to each visit at which time the emollients are weighed. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Average daily number of emollient usage | Two weeks | — |
| Average daily number of topical medication (other than emollient) usage | Two weeks | — |
| Investigator's Global Assessment (IGA) | Two weeks | At each visit, disease severity will be assessed using the Investigator's Global Assessment (IGA). |
| Eczema Area and Severity Index (EASI) | Two weeks | At each visit, disease severity will be assessed using the Eczema Area and Severity Index (EASI). |
Countries
South Korea
Outcome results
None listed